An intriguing Fibromyalgia treatment appears, in its preliminary stages, to be working. A powdered form of Ketiotifen (which is not available yet in the US) may be turning down the activity of important immune cells called mast cells that recent research suggests could be contributing to the pain and fatigue in fibromyalgia (FM) and perhaps even chronic fatigue syndrome (ME/CFS).
When the Largest Organ Goes Bad
The road to the Ketiotifen FM trial probably began, oddly enough, with the skin and the recognition that high rates of allodynia (pain upon touching) occur in fibromyalgia. Hyperalgesia (increased pain sensitivity) is present in ME/CFS but the allodynia in FM can be so severe that simply having clothing touching the skin can be excruciating…Adrienne Delwo at Aboutme.com describes the allodynia like this
” (it) makes your clothes hurt when they touch or brush your skin…(it) makes a sheet feel like sandpaper, and turns a light touch into searing pain.”
Fibromyalgia Studies Suggest Mast Cell Link
1990 and 1997 skin studies found high levels of IgG deposits in the skin that appeared to be caused by mast cell activity. Nine years later a 2008 FM study suggesting immune problems in fibromyalgia pointed an arrow at mast cells, but it wasn’t until 2010 that a Spanish FM study looked again at the skin – and found greatly increased levels of mast cells in the skin of every FM patient tested – a high positive rate for any disorder.
At that point, Ang, a frustrated physician/researcher not happy with a 30% success rate for FM approved drugs got busy. When preliminary results from his small NIH funded Ketiotifen FM study suggested the drug was working; he stated “I am quite excited. I think we are on the right track. The most rewarding thing I think that I can tell you being a physician scientist, is hearing from patients that they are responding to the medication that we are testing.”
One patient who didn’t know but assumed she was on the medication was pain free for the first time in years; “I was sure I had medicine, not the placebo. I was pain free. It was amazing. I was like I can’t believe this, I think they’re on to something.”
Mast cells have hardly been mentioned in ME/CFS or FM but they play an important role in inflammation and immune defense. Researchers know pain-production is up and pain inhibition is down in FM but the why this is happening is unclear. One theory suggests continuing pain signals from the body have put patients central nervous systems on alert and over-reacting …and here’s where mast cells come in.
Mast cells are found close to sensory nerve endings and blood vessels…When they’re activated they dump large amounts of immune factors near them. That process has lead some researchers to ask whether chronic mast cell activation could be sending the central nervous system into a tizzy.
The large number of symptoms in FM and ME/CFS suggest problems with sensory data processing could be present. Both the Lights and Dr. Baraniuk believe sensory data filtering problems pay a key role in ME/CFS/FM. Ang’s thesis was that if he could calm down the mast cells, their grip on the central nervous system might diminish, allowing it to relax and the pain to disappear.
“So my hypothesis is that if we quiet these immune cells then it will not send too many signals to the peripheral nerve endings and therefore would lessen the transmission of signals or pain to the brain and spinal chord and hopefully reduce the overall pain”
That’s one part of the process and there may be another. The systemic effects of large-scale mast cell degranulation into the blood causes several symptoms very familiar to ME/CFS patients including fatigue, pain, dizziness, heart racing, etc.
The ‘Grand Maestro’s: ME/CFS Researcher Proposes Mast Cell Link
Enter Tufts University researcher Theorharis Theorharides. For years Theorharides has believed that mast cell activities play a role in a number of chronic illnesses including autism, fibromyalgia, ME/CFS, interstitial cystitus, IBS, migraines, cardiovascular disorders, asthma and multiple sclerosis.
With over 15 papers published thus far this year and over 300 to his credit, Theoharides is a busy researcher and in 2006 he was awarded an NIH grant (later extended) to study mast cells in ME/CFS (using an animal model). He spoke at the State of the Knowledge Conference on ME/CFS in 2011 and has developed a series of neutraceuticals to combat mast cell release for a number of disorders.
Theoharides also believes the almost ubiquitous problems with stress in CFS are caused by stress induced mast cell releases triggering abnormal neuronal activity and blood vessel problems. ( He also believes mast cell activity may cause leaks in the blood:brain barrier resulting in neuroinflammation. Interestingly, Theoharides has found that mercury, an oft tested substance by alternative doctors, but a ignored factor by the research community, can also increase BBB permeability.)
Theoharides theory is predicated, to some extent, on the success some people with ME/CFS have had with amytriptyline, an antidepressant his work suggests has anti-histamine factors. Dr. Cheney has speculated that another commonly used drug in ME/CFS, doxepin elixir, was effective because of its ability to control the histamine production in the brain. He called the histamine receptors ‘the grand maestro’s of the central nervous system.
Problems Standing Linked to Mast Cell Activation in POTS Patients
But that’s not all. Earlier we noted that mast cell degranulation can cause dizziness and reduced blood pressure. Biaggioni, an ME/CFS researcher studying orthostatic intolerance noted that mast cells are “strategically positioned to modulate sympathetic (nervous system (SNS) activity” – a key system in ME/CFS. In a small 2005 study he described a process by which mast cell activation (MCA) caused orthostatic intolerance, particularly in patients who experienced ‘flushing’.
Intriguingly neuropeptide Y – a proposed biomarker in chronic fatigue syndrome – can induce mast cell degranulation and a subsequent lowering of blood pressure. Biaggioni found that POTS (postural tachycardia syndrome) patients with mast cell activation experienced episodes of flushing, shortness of breath, headache, lightheadedness, excessive urination, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. These symptoms could be set off by such normally innocuous things as standing for long periods, exercise, premenstrual cycle, meals, and sexual intercourse.
Biaggioni triggered mast cell activation by having POTS patients stand for 30 minutes and/or exercising on a treadmill and then determining if they experienced flushing and high levels of methylhistamine.
Biaggioni noted that beta blockers should be used with caution as they can induce further mast cell activation in patients with MDA. He also noted a process whereby exercise could very well be causing mast cell activation in some POTS (ME/CFS) patient…which brings up the possibility of a condition called “Exercise Anaphylaxis” .
Exercise anaphylaxis occurs when exercise triggers mast cells to spill their guts causing itching skins, hives, flushing, wheezing, nausea, abdominal cramping, and diarrhea. When the activity stops the condition usually disappears which is very different than in ME/CFS,which is not to say that its not happening in some people with ME/CFS.
If physical activity continues, patients may experience reduced blood pressure, edema and ultimately cardiovascular collapse Liz at POTSRecovery.com describes a sudden drop in blood pressure while exercising that Dr. Levine suggested may have been due to exercise induced anaphylaxis.. It might be a good idea for any CFS patients experiencing flushing, cramping, wheezing, etc. during exercise to get some tests done.
Diagnosing A Mast Cell Disorder
First described in 1991 mast cell activation syndrome (MCAS) is certainly underdiagnosed and much remains to be learned about it. 150,000 mostly undiagnosed people are believed to have MCAS in the US. It has some intriguing commonalities with ME/CFS.
For one it can affect virtually every organ system without causing abnormalities on routine tests. Secondly, a recent overview suggested mast cell activation disorder should be suspected in patients who experience chronic multisystem involvement. Symptoms usually wax and wane quite a bit earlier in the disorder but often occur all the time later on.
Mast cell activation disease ….affect(s) functions in potentially every organ system, often without causing abnormalities in routine laboratory or radiologic testing….Mast cell activation disease is now appreciated to likely be considerably prevalent and thus should be considered routinely in the differential diagnosis of patients with chronic multisystem polymorbidity or patients in whom a definitively diagnosed major illness does not well account for the entirety of the patient’s presentation. From Molderlings (Mast Cell Activation Disease -A concise practical guide for diagnostic workup and therapeutic options)
Symptoms can differ depending in which organ the over-active mast cells are present. Some of the major symptoms include fatigue, skin lesions and itching, abdominal discomfort, nausea, diarrhea and vomiting, intolerance of odors, low blood pressure, frequent infections, bone or muscle pain, malabsorption, headache…Skin lesions are common but they do not occur in all patients.
Molderling reports MCAS has been associated with fibromyalgia, interstitial cystitis and irritable bowel syndrome.
Some tests can aid diagnosis but Moldering notes that only a handful of the more than 60 substances released by mast cells are testable; a negative test result does not necessarily mean you don’t have MCAS.
Darier’s sign – high histamine releases can cause the skin of some people with MCAS to become itchy, swollen and red after its been stroked. (Note that histamine is just one of many substances released by mast cells and it may not always be released in MCAS.)
Blood and Urine Tests
Increased level of the following may occur
- Tryptase, histamine, heparin blood
- Eosinophilia, basophilia, monocytosis activity
- Serum chromagranin A
- Serum and urinary leukotriene and prostaglandin isoforms
- Urine methylhistamine (only elevated when people are experiencing flushing episodes. Biaggioni induced flushing in his study by having patients exercise).
The connection to exercise, the ability to cause dizziness, the possible connection to pain and sensory problems, the fluctuating symptoms…….the associations are intriguing. Dr. Janelle Sinclair reports that histamine levels can cause anxiety, depression and other problems misdiagnosed as mood disorders. There’s a lot left to learn about mast cells and disease.
Histamine Blockers and Methyldopa
Biaggioni reports the orthostatic intolerant patients improved when treated with H1 (eg Benadryl) and H2 histamine receptor blockers (eg. Claritin, Allegra) or with α-methyldopa, or with a combination of both. (His study examining methyldopa and other treatments in POTs patients is due to wrap up at the end of this year.) The use of β-blockers in MCAS patients, on the other hand, appeared to trigger more mast cell activity in some patents.
Quercetin and Luteolin
Thus far preliminary results suggest Ketiotifen may be helping in Fibromyalgia but Theoharides, believes better mast cell ‘stabilizers’ are available. Ketiotifen, he reports, is effective at blocking the release of allergy producing immune factors but does not block pro-inflammatory cytokines, which he believes are key in ME/CFS and other disorders.
Theoharides 2012 study found that quercetin and luteolin were more effective than cromolyn, a mast cell stabilizer, at reducing cytokine release and he’s produced a patent-protected neutraceutical product called Neuroprotek (available without prescription) he believes will work better. The problem with many neutraceuticals is getting enough of their active factors into the system to make a difference. Theoharides believes using olive kernel oil in his products significantly increases the flavinoids availability.
The mast cell ME/CFS/FM theory is quite preliminary and mast cell research is a young field but with their fatigue and pain producing and vasodilatory properties mast cells could fit FM/ME/CFS very well. With mast cells firming up as a potential cause in FM and with Theorharides ongoing interest in ME/CFS it may only be a matter of time before we see more research and possibly treatment trials.
For interested fibromyalgia patients Ang’s Indiana University study is still recruiting. For additional information about the study, contact the Indiana University Clinical Research Center for Fibromyalgia at 317-274-1755 or email firstname.lastname@example.org.
Support Phoenix Rising
(Why not support Phoenix Rising with a $5 , $10, $15, $20 or more monthly ‘subscription’. Click on the Subscribe button and look on the right hand side of the page for options )44 comments